<DOC>
	<DOCNO>NCT00799266</DOCNO>
	<brief_summary>This study design evaluate efficacy safety zoledronic acid compare placebo osteoporotic child adolescent treat glucocorticoid</brief_summary>
	<brief_title>A Research Study Zoledronic Acid Children Adolescents With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Key Inclusion criterion 1 . Written inform consent study related procedure 2 . Children , male female , 5 17 year age Visit 1 study 3 . Confirmed diagnosis chronic inflammatory condition include rheumatic condition inflammatory bowel disease ( IBD ) nonmalignant condition require treatment systemic glucocorticoid ( include limit rheumatic condition , Inflammatory Bowel Disease , Duchenne muscular dystrophy , Nephrotic syndrome ) , require treatment systemic glucocorticoid ( i.v . oral ) within 12 month precede enrollment study ( duration ) 4 . LSBMD Zscore 0.5 worse confirm central image vendor 5 . Evidence least 1 vertebral compression fracture ( least Genant Grade 1 vertebral compression radiographic sign vertebral compression ) confirm central reading OR At least one low OR 2 upper extremity longbone , lowtrauma , fracture occur sometime within 2 year precede enrollment study , confirm central reading radiological report . ( Low trauma fracture define fall stand height less ) . Key Exclusion criterion 1 . History primary bone disease ( osteogenesis imperfecta , idiopathic juvenile osteoporosis , rickets/osteomalacia ) . 2 . Prior use bisphosphonates sodium fluoride ( dose osteoporosis dental hygiene ) . 3 . Any medical condition might interfere evaluation LSBMD , severe scoliosis spinal fusion . 4 . Hypocalcemia hypophosphatemia : value ( agematched ) normal range screen 5 . Vitamin D deficiency ( serum 25hydroxy vitamin D concentration &lt; 20 ng/mL &lt; 50 nmol/L ) screen 6 . Renal impairment define estimate glomerular filtration rate ( GFR ) &lt; 60 mL/min/1.73 m2 screen base Schwartz formula ; serum creatinine increase Visit 1 Visit 2 great 0.5 mg/dL ( 44.2 Î¼mol/L ) 7 . Female patient child bear potential eligible pregnant/nonlactating . Females child bear potential must practice medically acceptable form birth control great 2 month prior screen visit consent pregnancy test study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Osteoporosis , child adolescent , zoledronic acid , chronic inflammation , Duchenne muscular dystrophy , glucocorticoid</keyword>
</DOC>